img

Global Cardiac Marker Testing Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Cardiac Marker Testing Market Research Report 2024

According to MRAResearch’s new survey, global Cardiac Marker Testing market is projected to reach US$ 3569.4 million in 2033, increasing from US$ 2462.1 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardiac Marker Testing market research.
Key companies engaged in the Cardiac Marker Testing industry include Roche Diagnostics, Abbott Laboratories, Siemens, Danaher Corporation, Alere Inc, BioMerieux, LSI Medience Corporation, Ortho Clinical Diagnostics and Randox Laboratories Ltd, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cardiac Marker Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cardiac Marker Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cardiac Marker Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Roche Diagnostics
Abbott Laboratories
Siemens
Danaher Corporation
Alere Inc
BioMerieux
LSI Medience Corporation
Ortho Clinical Diagnostics
Randox Laboratories Ltd
Guangzhou Wondfo Biotech
Segment by Type
Chemiluminescence
Immunofluorescence
ELISA
Immunochromatography
Others

Segment by Application


Pharmaceutical Companies
Reagents Manufacturers
Imaging Instrument Providers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cardiac Marker Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Marker Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Chemiluminescence
1.2.3 Immunofluorescence
1.2.4 ELISA
1.2.5 Immunochromatography
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cardiac Marker Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Companies
1.3.3 Reagents Manufacturers
1.3.4 Imaging Instrument Providers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Marker Testing Market Perspective (2018-2033)
2.2 Cardiac Marker Testing Growth Trends by Region
2.2.1 Global Cardiac Marker Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cardiac Marker Testing Historic Market Size by Region (2018-2023)
2.2.3 Cardiac Marker Testing Forecasted Market Size by Region (2024-2033)
2.3 Cardiac Marker Testing Market Dynamics
2.3.1 Cardiac Marker Testing Industry Trends
2.3.2 Cardiac Marker Testing Market Drivers
2.3.3 Cardiac Marker Testing Market Challenges
2.3.4 Cardiac Marker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Marker Testing Players by Revenue
3.1.1 Global Top Cardiac Marker Testing Players by Revenue (2018-2023)
3.1.2 Global Cardiac Marker Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cardiac Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cardiac Marker Testing Revenue
3.4 Global Cardiac Marker Testing Market Concentration Ratio
3.4.1 Global Cardiac Marker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Marker Testing Revenue in 2022
3.5 Cardiac Marker Testing Key Players Head office and Area Served
3.6 Key Players Cardiac Marker Testing Product Solution and Service
3.7 Date of Enter into Cardiac Marker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Marker Testing Breakdown Data by Type
4.1 Global Cardiac Marker Testing Historic Market Size by Type (2018-2023)
4.2 Global Cardiac Marker Testing Forecasted Market Size by Type (2024-2033)
5 Cardiac Marker Testing Breakdown Data by Application
5.1 Global Cardiac Marker Testing Historic Market Size by Application (2018-2023)
5.2 Global Cardiac Marker Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cardiac Marker Testing Market Size (2018-2033)
6.2 North America Cardiac Marker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cardiac Marker Testing Market Size by Country (2018-2023)
6.4 North America Cardiac Marker Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Marker Testing Market Size (2018-2033)
7.2 Europe Cardiac Marker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cardiac Marker Testing Market Size by Country (2018-2023)
7.4 Europe Cardiac Marker Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Marker Testing Market Size (2018-2033)
8.2 Asia-Pacific Cardiac Marker Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cardiac Marker Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Cardiac Marker Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiac Marker Testing Market Size (2018-2033)
9.2 Latin America Cardiac Marker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cardiac Marker Testing Market Size by Country (2018-2023)
9.4 Latin America Cardiac Marker Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Marker Testing Market Size (2018-2033)
10.2 Middle East & Africa Cardiac Marker Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cardiac Marker Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Cardiac Marker Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Detail
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Cardiac Marker Testing Introduction
11.1.4 Roche Diagnostics Revenue in Cardiac Marker Testing Business (2018-2023)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Cardiac Marker Testing Introduction
11.2.4 Abbott Laboratories Revenue in Cardiac Marker Testing Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Siemens
11.3.1 Siemens Company Detail
11.3.2 Siemens Business Overview
11.3.3 Siemens Cardiac Marker Testing Introduction
11.3.4 Siemens Revenue in Cardiac Marker Testing Business (2018-2023)
11.3.5 Siemens Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Detail
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Cardiac Marker Testing Introduction
11.4.4 Danaher Corporation Revenue in Cardiac Marker Testing Business (2018-2023)
11.4.5 Danaher Corporation Recent Development
11.5 Alere Inc
11.5.1 Alere Inc Company Detail
11.5.2 Alere Inc Business Overview
11.5.3 Alere Inc Cardiac Marker Testing Introduction
11.5.4 Alere Inc Revenue in Cardiac Marker Testing Business (2018-2023)
11.5.5 Alere Inc Recent Development
11.6 BioMerieux
11.6.1 BioMerieux Company Detail
11.6.2 BioMerieux Business Overview
11.6.3 BioMerieux Cardiac Marker Testing Introduction
11.6.4 BioMerieux Revenue in Cardiac Marker Testing Business (2018-2023)
11.6.5 BioMerieux Recent Development
11.7 LSI Medience Corporation
11.7.1 LSI Medience Corporation Company Detail
11.7.2 LSI Medience Corporation Business Overview
11.7.3 LSI Medience Corporation Cardiac Marker Testing Introduction
11.7.4 LSI Medience Corporation Revenue in Cardiac Marker Testing Business (2018-2023)
11.7.5 LSI Medience Corporation Recent Development
11.8 Ortho Clinical Diagnostics
11.8.1 Ortho Clinical Diagnostics Company Detail
11.8.2 Ortho Clinical Diagnostics Business Overview
11.8.3 Ortho Clinical Diagnostics Cardiac Marker Testing Introduction
11.8.4 Ortho Clinical Diagnostics Revenue in Cardiac Marker Testing Business (2018-2023)
11.8.5 Ortho Clinical Diagnostics Recent Development
11.9 Randox Laboratories Ltd
11.9.1 Randox Laboratories Ltd Company Detail
11.9.2 Randox Laboratories Ltd Business Overview
11.9.3 Randox Laboratories Ltd Cardiac Marker Testing Introduction
11.9.4 Randox Laboratories Ltd Revenue in Cardiac Marker Testing Business (2018-2023)
11.9.5 Randox Laboratories Ltd Recent Development
11.10 Guangzhou Wondfo Biotech
11.10.1 Guangzhou Wondfo Biotech Company Detail
11.10.2 Guangzhou Wondfo Biotech Business Overview
11.10.3 Guangzhou Wondfo Biotech Cardiac Marker Testing Introduction
11.10.4 Guangzhou Wondfo Biotech Revenue in Cardiac Marker Testing Business (2018-2023)
11.10.5 Guangzhou Wondfo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cardiac Marker Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Chemiluminescence
Table 3. Key Players of Immunofluorescence
Table 4. Key Players of ELISA
Table 5. Key Players of Immunochromatography
Table 6. Key Players of Others
Table 7. Global Cardiac Marker Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Cardiac Marker Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Cardiac Marker Testing Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cardiac Marker Testing Market Share by Region (2018-2023)
Table 11. Global Cardiac Marker Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Cardiac Marker Testing Market Share by Region (2024-2033)
Table 13. Cardiac Marker Testing Market Trends
Table 14. Cardiac Marker Testing Market Drivers
Table 15. Cardiac Marker Testing Market Challenges
Table 16. Cardiac Marker Testing Market Restraints
Table 17. Global Cardiac Marker Testing Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cardiac Marker Testing Market Share by Players (2018-2023)
Table 19. Global Top Cardiac Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Marker Testing as of 2022)
Table 20. Ranking of Global Top Cardiac Marker Testing Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cardiac Marker Testing Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cardiac Marker Testing Product Solution and Service
Table 24. Date of Enter into Cardiac Marker Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cardiac Marker Testing Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cardiac Marker Testing Revenue Market Share by Type (2018-2023)
Table 28. Global Cardiac Marker Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Cardiac Marker Testing Revenue Market Share by Type (2024-2033)
Table 30. Global Cardiac Marker Testing Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cardiac Marker Testing Revenue Market Share by Application (2018-2023)
Table 32. Global Cardiac Marker Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Cardiac Marker Testing Revenue Market Share by Application (2024-2033)
Table 34. North America Cardiac Marker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Cardiac Marker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cardiac Marker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Cardiac Marker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Cardiac Marker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cardiac Marker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Cardiac Marker Testing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Cardiac Marker Testing Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cardiac Marker Testing Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Cardiac Marker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Cardiac Marker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cardiac Marker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Cardiac Marker Testing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Cardiac Marker Testing Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cardiac Marker Testing Market Size by Country (2024-2033) & (US$ Million)
Table 49. Roche Diagnostics Company Detail
Table 50. Roche Diagnostics Business Overview
Table 51. Roche Diagnostics Cardiac Marker Testing Product
Table 52. Roche Diagnostics Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 53. Roche Diagnostics Recent Development
Table 54. Abbott Laboratories Company Detail
Table 55. Abbott Laboratories Business Overview
Table 56. Abbott Laboratories Cardiac Marker Testing Product
Table 57. Abbott Laboratories Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 58. Abbott Laboratories Recent Development
Table 59. Siemens Company Detail
Table 60. Siemens Business Overview
Table 61. Siemens Cardiac Marker Testing Product
Table 62. Siemens Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 63. Siemens Recent Development
Table 64. Danaher Corporation Company Detail
Table 65. Danaher Corporation Business Overview
Table 66. Danaher Corporation Cardiac Marker Testing Product
Table 67. Danaher Corporation Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 68. Danaher Corporation Recent Development
Table 69. Alere Inc Company Detail
Table 70. Alere Inc Business Overview
Table 71. Alere Inc Cardiac Marker Testing Product
Table 72. Alere Inc Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 73. Alere Inc Recent Development
Table 74. BioMerieux Company Detail
Table 75. BioMerieux Business Overview
Table 76. BioMerieux Cardiac Marker Testing Product
Table 77. BioMerieux Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 78. BioMerieux Recent Development
Table 79. LSI Medience Corporation Company Detail
Table 80. LSI Medience Corporation Business Overview
Table 81. LSI Medience Corporation Cardiac Marker Testing Product
Table 82. LSI Medience Corporation Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 83. LSI Medience Corporation Recent Development
Table 84. Ortho Clinical Diagnostics Company Detail
Table 85. Ortho Clinical Diagnostics Business Overview
Table 86. Ortho Clinical Diagnostics Cardiac Marker Testing Product
Table 87. Ortho Clinical Diagnostics Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 88. Ortho Clinical Diagnostics Recent Development
Table 89. Randox Laboratories Ltd Company Detail
Table 90. Randox Laboratories Ltd Business Overview
Table 91. Randox Laboratories Ltd Cardiac Marker Testing Product
Table 92. Randox Laboratories Ltd Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 93. Randox Laboratories Ltd Recent Development
Table 94. Guangzhou Wondfo Biotech Company Detail
Table 95. Guangzhou Wondfo Biotech Business Overview
Table 96. Guangzhou Wondfo Biotech Cardiac Marker Testing Product
Table 97. Guangzhou Wondfo Biotech Revenue in Cardiac Marker Testing Business (2018-2023) & (US$ Million)
Table 98. Guangzhou Wondfo Biotech Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cardiac Marker Testing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cardiac Marker Testing Market Share by Type: 2022 VS 2033
Figure 3. Chemiluminescence Features
Figure 4. Immunofluorescence Features
Figure 5. ELISA Features
Figure 6. Immunochromatography Features
Figure 7. Others Features
Figure 8. Global Cardiac Marker Testing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Cardiac Marker Testing Market Share by Application: 2022 VS 2033
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Reagents Manufacturers Case Studies
Figure 12. Imaging Instrument Providers Case Studies
Figure 13. Others Case Studies
Figure 14. Cardiac Marker Testing Report Years Considered
Figure 15. Global Cardiac Marker Testing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Cardiac Marker Testing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Cardiac Marker Testing Market Share by Region: 2022 VS 2033
Figure 18. Global Cardiac Marker Testing Market Share by Players in 2022
Figure 19. Global Top Cardiac Marker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Marker Testing as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Cardiac Marker Testing Revenue in 2022
Figure 21. North America Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Cardiac Marker Testing Market Share by Country (2018-2033)
Figure 23. United States Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Cardiac Marker Testing Market Share by Country (2018-2033)
Figure 27. Germany Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Cardiac Marker Testing Market Share by Region (2018-2033)
Figure 35. China Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Cardiac Marker Testing Market Share by Country (2018-2033)
Figure 43. Mexico Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Cardiac Marker Testing Market Share by Country (2018-2033)
Figure 47. Turkey Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Cardiac Marker Testing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Roche Diagnostics Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 50. Abbott Laboratories Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 51. Siemens Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 52. Danaher Corporation Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 53. Alere Inc Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 54. BioMerieux Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 55. LSI Medience Corporation Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 56. Ortho Clinical Diagnostics Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 57. Randox Laboratories Ltd Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 58. Guangzhou Wondfo Biotech Revenue Growth Rate in Cardiac Marker Testing Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed